Women-led startups deliver higher returns than their counterparts. Almost twice as much revenue per dollar invested. And while they...
Biotechs generally need access to a lot of capital in order to bring their therapeutics to market. The traditional IPO route was the...
There have been a record number of SPACs formed in 2020 and the first two months of 2021. The number of SPACs looking for good merger...
Its annual performance review season at our firm and as I take intentional steps to counteract my own implicit biases when writing...
In one of the first public statements issued by the SEC during the Biden Administration, Acting Chair Lee announced that the SEC would...
A perverse combination of economic effects and forecasts related to the pandemic and clumsy trade moves in the last Administration have...
No provision of the murky Federal Superfund statute is more murky than Section 113, the applicable statutes of limitations. For decades...
The Securities and Exchange Commission has, for a very long time, reminded issuers of the need to disclose negative information along...
The volatile economic and market conditions of the past 12 months have left many seeking promising returns from what they believe are...
The Biden Administration's focus on climate change and its impacts is beginning to be reflected in government policy. Climate change...
A new study tells us what we already knew -- the coastal communities of the Commonwealth of Massachusetts are going to suffer...
The already substantial collaboration between tech and medicine should be encouraged and financed post-pandemic to make conduct of...
With the annual reporting season upon us, it's time for public companies to reassess their risk factor disclosures, particularly in light...
The ability of companies to go pubic via an initial public offering is very cyclical. When the market is on the number of IPOs skyrockets...
Superfund cases can go on for a bit. In this one, EPA issued a Record of Decision in 2012 selecting a remedy for the Centredale Manor...
Precision Medicine is a continuing new frontier in cancer research. New samples and additional cell lines have been created. The robust...